抗生素使用与新发ICD编码诊断年龄相关性黄斑变性的关联:一项大型全国性病例对照研究
研究基于2008至2017年全国商业健康保险理赔数据库,对55岁及以上新发AMD患者开展病例对照分析,按年龄、年份、地区、贫血、高血压及共病指数一对一匹配,评估索引日期前两年抗生素暴露与新发ICD编码AMD诊断的关联。氨基糖苷类(OR=1.24;95%CI,1.22-1.26)和氟喹诺酮类(OR=1.13;95%CI,1.12-1.14)与新发ICD编码AMD诊断的比值比最高,广谱抗生素的比值比接近窄谱抗生素的三倍。作者认为,抗生素累积暴露越多可能越与AMD发生相关,该发现需前瞻性研究进一步探讨。
要点
- 氨基糖苷类(OR=1.24;95%CI,1.22-1.26)和氟喹诺酮类(OR=1.13;95%CI,1.12-1.14)与新发ICD编码AMD诊断的比值比最高。
- 广谱抗生素(OR=1.15;95%CI,1.13-1.16)与新发ICD编码AMD诊断的比值比接近窄谱抗生素(OR=1.05;95%CI,1.03-1.07)的三倍。
- 抗生素处方累积数量或抗生素供应天数越多,新发ICD编码AMD诊断的比值比越高,呈频率和疗程依赖关联。
核心结论
- 更大量的抗生素累积暴露,尤其是氟喹诺酮类、氨基糖苷类及广谱覆盖抗生素,可能与AMD的发生相关,该发现需前瞻性研究进一步探讨。
研究设计与样本
- 研究为病例对照分析,对象为2008至2017年间来自全国商业健康保险理赔数据库的55岁及以上新发AMD患者;病例与对照按年龄、年份、地区、贫血、高血压和共病指数一对一匹配,并采用条件多变量logistic回归(校正AMD危险因素)计算OR和95%CI。
主要发现
- 氨基糖苷类暴露与新发ICD编码AMD诊断的OR=1.24(95%CI,1.22-1.26)。
- 氟喹诺酮类暴露与新发ICD编码AMD诊断的OR=1.13(95%CI,1.12-1.14)。
- 广谱抗生素与新发ICD编码AMD诊断的OR=1.15(95%CI,1.13-1.16),窄谱抗生素的OR=1.05(95%CI,1.03-1.07)。
- 抗生素处方累积数量或抗生素供应天数越多,新发ICD编码AMD诊断的比值比越高,呈频率和疗程依赖关联。
关键数值与推荐
- 氨基糖苷类暴露:OR=1.24(95%CI,1.22-1.26);氟喹诺酮类暴露:OR=1.13(95%CI,1.12-1.14)。
- 广谱抗生素:OR=1.15(95%CI,1.13-1.16);窄谱抗生素:OR=1.05(95%CI,1.03-1.07)。
- 抗生素累积处方数量或供应天数增加与新发ICD编码AMD诊断的比值比升高相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出,该发现需前瞻性研究进一步探讨。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The widespread use of antibiotics has many well-documented impacts on the human microbiome, which may be associated with the development of various inflammatory diseases. Despite age-related macular degeneration (AMD) featuring an inflammatory pathogenesis, the relationship between antibiotics and AMD has remained unexplored. We conducted the first study to determine the association between antibiotic exposure and a new-onset International Classification of Diseases (ICD) diagnosis of AMD. METHODS: We performed a case-control analysis of patients aged 55 and older with new-onset AMD between 2008 and 2017 from a nationwide commercial health insurance claims database. Exposure to antibiotics in the two years before the index date was determined for cases and controls matched one-to-one by age, year, region, anemia, hypertension, and a comorbidity index. Conditional multivariable logistic regression, adjusted for AMD risk factors, was performed to calculate odd ratios (OR) and 95% confidence intervals (CI). RESULTS: Among the antibiotic classes, exposure to aminoglycosides (OR = 1.24; 95% CI, 1.22-1.26) and fluoroquinolones (OR = 1.13; 95% CI, 1.12-1.14) was associated with the greatest odds of a new-onset ICD code diagnosis of AMD. Broad-spectrum antibiotics were associated with nearly three times greater odds of a new-onset ICD code diagnosis of AMD (OR = 1.15; 95% CI, 1.13-1.16) compared to narrow-spectrum antibiotics (OR = 1.05; 95% CI, 1.03-1.07). We also identified a frequency- and duration-dependent association, with a greater cumulative number of antibiotic prescriptions or day supply of antibiotics conferring increased odds of a new-onset ICD code diagnosis of AMD. CONCLUSIONS: Greater cumulative exposure to antibiotics, particularly fluoroquinolones, aminoglycosides, and those with broader-spectrum coverage, may be associated with the development of AMD, a finding that requires further investigation using prospective studies.
引用
- Moir J, Hyman M, Wang J, et al. The Association of Antibiotic Use and the Odds of a New-Onset ICD Code Diagnosis of Age-Related Macular Degeneration: A Large National Case-Control Study. Invest Ophthalmol Vis Sci. 2023. PMID: 37682568. doi:10.1167/iovs.64.12.14
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。